Spectrum Pharmaceuticals, Inc. (SPPI) financial statements (2021 and earlier)

Company profile

Business Address 11500 S. EASTERN AVE., SUITE 240
HENDERSON, NV 89052
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:180224204228158140133
Cash and cash equivalents46  227158140130
Short-term investments13431460  3
Other undisclosed cash, cash equivalents, and short-term investments 193158    
Receivables003032403071
Inventory, net of allowances, customer advances and progress billings  46949
Inventory  46949
Prepaid expense4101010444
Other current assets      18
Other undisclosed current assets21042613(12)
Total current assets:187244251278217191222
Noncurrent Assets
Operating lease, right-of-use asset24
Property, plant and equipment41201011
Intangible assets, net (including goodwill)  130155182208248
Goodwill  1818181818
Intangible assets, net (excluding goodwill)  112137164190230
Regulated entity, other noncurrent assets      2
Other noncurrent assets441054302118
Other undisclosed noncurrent assets      (2)
Total noncurrent assets:1019140210212230268
TOTAL ASSETS:197263391487429421490
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:44416252484227
Accounts payable3432453430279
Accrued liabilities1189979
Employee-related liabilities98109988
Other undisclosed accounts payable and accrued liabilities(1)      
Debt 2 38   
Deferred compensation liability   5875
Deferred revenue and credits43610
Contract with customer, liability5
Other undisclosed current liabilities920191162268
Total current liabilities:5362861106676109
Noncurrent Liabilities
Liabilities, other than long-term debt91167171518
Deferred revenue and credits0000
Deferred compensation liability, classified      5
Deferred tax liabilities, net  777
Other liabilities911661076
Other undisclosed noncurrent liabilities  1620111117108
Total noncurrent liabilities:9112126127132126
Total liabilities:6373108136193208235
Stockholders' equity
Stockholders' equity attributable to parent, including:134190283351236213255
Common stock0000000
Additional paid in capital1,021918887837640552539
Accumulated other comprehensive income (loss)(2)(3)(4)16(2)(5)(1)
Accumulated deficit(885)(724)(600)(502)(403)(334)(283)
Other undisclosed stockholders' equity attributable to parent     00
Total stockholders' equity:134190283351236213255
TOTAL LIABILITIES AND EQUITY:197263391487429421490

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1 109128146137187
Revenue, net128146163187
Gain (loss) on disposition of assets for financial service operations1(13) 
Cost of revenue (0)(19)(39)(62)(66)(26)
Cost of goods and services sold   (32)(34)(38)(24)
Gross profit:1(0)91898571160
Operating expenses(170)(141)(222)(186)(146)(137)(192)
Other undisclosed operating income (loss)(1)    260
Operating loss:(170)(141)(131)(97)(62)(41)(32)
Nonoperating income (expense)(2)(4)11(11)(9)(10)(12)
Foreign currency transaction loss, before tax      (6)
Other nonoperating income (expense)(3)(9)1001(1)(4)
Interest and debt expense  (3)(8)(10)(9)(9)
Loss from continuing operations before equity method investments, income taxes:(171)(145)(123)(116)(81)(60)(53)
Other undisclosed income from continuing operations before income taxes  381099
Loss from continuing operations before income taxes:(171)(145)(120)(108)(71)(50)(44)
Income tax expense (benefit)09(0)172(0)(2)
Net loss:(171)(135)(120)(91)(69)(51)(46)
Other undisclosed net income attributable to parent1023     
Net loss available to common stockholders, diluted:(161)(113)(120)(91)(69)(51)(46)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(171)(135)(120)(91)(69)(51)(46)
Other comprehensive loss      (2)
Comprehensive loss:(171)(135)(120)(91)(69)(51)(47)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1223(2)184(4) 
Comprehensive loss, net of tax, attributable to parent:(159)(112)(123)(74)(65)(55)(47)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: